Clinical Trial Update: Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension [Phase 2]

View source ↗

Summary

Phase 2 extension study (Depressed MIND3) evaluating nicotine dosing for depressive mood. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Depressive Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING